$PHAT Phathom Pharmaceuticals PDUFA Friday July 19th. Short Interest 30%


Could be interesting. Run up is just starting. Still has lots of room to run before hitting 52 week high. FDA has already approved drug for GERD so they should approve this application also.

Phathom Pharmaceuticals is a small cap company so has lots of potential for movement. May be worth looking into for a short term trade. Make sure to do your own due diligence. This is just to inform the sub of the upcoming catalyst.


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *